While more than 1 million Medicare beneficiaries had a diagnosis of opioid use disorder in 2020, fewer than 16% of those beneficiaries received medication to treat their condition, according to a new report from the Office of Inspector General. They accounted for fewer than one in 6 of all Medicare beneficiaries with opioid use disorder.
Medicare patients challenged to access opioid use disorder medication, OIG finds
